Anna Maria Szota

Dr. Anna Maria Szota

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2014 in Pharmacological Reports
Verified
Journal Article
Closed access
EOEWA Alicja OGŁODEK
EWA Alicja OGŁODEK
ASAnna Maria Szota
Anna Maria Szota
MJMarek Just
Marek Just
DMDanuta Moś
Danuta Moś
AAAleksander Araszkiewicz
Aleksander Araszkiewicz

1 October 2014 in Pharmacological Reports
Verified
Journal Article
Closed access
EOEWA Alicja OGŁODEK
EWA Alicja OGŁODEK
ASAnna Maria Szota
Anna Maria Szota
MJMarek J. Just
Marek J. Just
DMDanuta Moś
Danuta Moś
AAAleksander Araszkiewicz
Aleksander Araszkiewicz

1 February 2015 in Pharmacological Reports
Verified
Journal Article
Closed access
EOEWA Alicja OGŁODEK
EWA Alicja OGŁODEK
ASAnna Maria Szota
Anna Maria Szota
MJMarek J. Just
Marek J. Just
DMDanuta M. Moś
Danuta M. Moś
AAAleksander Araszkiewicz
Aleksander Araszkiewicz


1 August 2016 in Pharmacological Reports
Verified
Journal Article
Closed access
EOEWA Alicja OGŁODEK
EWA Alicja OGŁODEK
ASAnna Maria Szota
Anna Maria Szota
MJMarek J. Just
Marek J. Just
Adam R. SzromekAdam R. Szromek
Adam R. Szromek
AAAleksander Araszkiewicz
Aleksander Araszkiewicz

1 April 2016 in Neuropsychiatric Disease and Treatment
Verified
Journal Article
Open access
PDF file
EOEWA Alicja OGŁODEK
EWA Alicja OGŁODEK
ASAnna Maria Szota
Anna Maria Szota
MJMarek Jan Just
Marek Jan Just
AAAleksander Araszkiewicz
Aleksander Araszkiewicz
Adam R. SzromekAdam R. Szromek
Adam R. Szromek
Aim: Alexithymia is associated with limited cognitive processing of emotions by an individual suffering from recurrent urticaria and alexithymia and makes them focus on somatic manifestations of emotional arousal and on poorly controlled compulsive reactions to negative stimulation. Alexithymia is considered to be a personality trait, which, along with other factors, predisposes individuals toward developing somatic diseases. The aim of the study was to assess the measurement of alexithymic features in patients with recurrent urticaria and to assess the types of concurrent anxiety disorders and overall anxiety level. Methods: In order to diagnose clinical anxiety symptoms in patients, the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition and the Hamilton Anxiety Rating Scale were applied. Alexithymic features were measured by means of a shortened version of the Toronto Alexithymia Scale, characterized by high discrimination power, internal coherence, and reliability. Results: According to the Toronto Alexithymia Scale results, the greatest contributing factor was “inability to differentiate between feelings and bodily sensations”. This was observed in both males and females. Most frequently, the patients were found to suffer from generalized anxiety disorder and social phobia. Conclusion: Alexithymia may result from the difficulty associated with expressing emotions caused by anxiety disorders. Undergoing treatment for anxiety disorders may contribute to reduced exacerbation of urticaria.